Advertisement
Screener

BRIACELL THERAPEUTICS CORP. (BCTX) Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount

2.2 / 5 stars · 22/51 Roast Me

BRIACELL THERAPEUTICS CORP. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount

BRIACELL THERAPEUTICS CORP. (BCTX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of -$7.17 million for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-16.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2025-10-16

  • BRIACELL THERAPEUTICS CORP. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was -$7.17M.
  • BRIACELL THERAPEUTICS CORP. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was -$1.33M.
  • BRIACELL THERAPEUTICS CORP. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was -$5.48M.
  • BRIACELL THERAPEUTICS CORP. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2022 was -$7.25M.
Period endEffective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month
2025-07-31-$7.17M
10-K · filed 2025-10-16
2024-07-31-$1.33M
10-K · filed 2025-10-16
2023-07-31-$5.48M
10-K · filed 2024-10-29
2022-07-31-$7.25M
10-K · filed 2023-10-25
2021-07-31-$3.73M
10-K · filed 2022-10-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
PMGC Holdings Inc. (ELAB)United States$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98